Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanara MedTech (SMTI) Receivables (2016 - 2025)

Historic Receivables for Sanara MedTech (SMTI) over the last 15 years, with Q3 2025 value amounting to $12.1 million.

  • Sanara MedTech's Receivables fell 52.83% to $12.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.1 million, marking a year-over-year decrease of 52.83%. This contributed to the annual value of $13.5 million for FY2024, which is 5849.14% up from last year.
  • As of Q3 2025, Sanara MedTech's Receivables stood at $12.1 million, which was down 52.83% from $12.0 million recorded in Q2 2025.
  • In the past 5 years, Sanara MedTech's Receivables registered a high of $13.5 million during Q4 2024, and its lowest value of $2.1 million during Q3 2021.
  • Over the past 5 years, Sanara MedTech's median Receivables value was $7.2 million (recorded in 2023), while the average stood at $7.4 million.
  • Per our database at Business Quant, Sanara MedTech's Receivables skyrocketed by 15974.86% in 2022 and then crashed by 52.83% in 2025.
  • Sanara MedTech's Receivables (Quarter) stood at $2.9 million in 2021, then skyrocketed by 134.81% to $6.9 million in 2022, then grew by 23.44% to $8.5 million in 2023, then soared by 58.49% to $13.5 million in 2024, then fell by 10.54% to $12.1 million in 2025.
  • Its last three reported values are $12.1 million in Q3 2025, $12.0 million for Q2 2025, and $11.9 million during Q1 2025.